Abstract
In Japan, the respective prevalence of probable and possible diabetes increased respectively from 6.9 to 8.9 and from 6.8 to 13.2 million cases between 1997 and 2007 [1]. Probable diabetes cases are characterized by either high levels of glycated hemoglobin (≥ 6.1 %) or by receiving medication for type 2 diabetes. Possible diabetes cases are characterized by glycated hemoglobin levels ranging from 5.6 % to 6.1 % [1]. Within populations of Japanese men and women aged over 50 years, the prevalence of probable and possible diabetes has been reported to be as high as 30–40 % [1]. Although the prevalence of obesity (an important risk factor of type 2 diabetes) is lower in Japanese than in Western populations [2], the prevalence of type 2 diabetes is not dramatically lower [3]. While these epidemic proportions of type 2 diabetes among Japanese have mainly been attributed to genetic differences between Asian and Caucasian populations [4], some limited evidence also suggests the influence of environmental factors, such as diet. For example, magnesium is involved in glucose homeostasis and insulin action [5], and its protective effect against type 2 diabetes has been demonstrated by several prospective studies, including one involving a Japanese population.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kenko Eiyo Joho Kenkyukai. The National Health and Nutrition Survey in Japan, 2007. Tokyo: Daiichi-shuppan; 2010.
Huxley R, Omari A, Caterson ID. Obesity and diabetes. In: Ekoe JM, Rewers M, Williams R, Zimmet P, editors. The epidemiology of diabetes mellitus. 2nd ed. Chichester: Wiley-Blackwell; 2008.
International Diabetes Federation. IDF diabetes atlas. 4th ed. Brussels: International Diabetes Federation; 2009.
Yazaki Y, Kadowaki T. Combating diabetes and obesity in Japan. Nat Med. 2006;12:73–4.
Paolisso G, Scheen A, D’Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia. 1990;33:511–4.
Kenko Eiyo Joho Kenkyukai. The National Health and Nutrition Survey in Japan, 2008. Tokyo: Daiichi-shuppan; 2011.
Ministry of Health Labour and Welfare, Japan. Dietary reference intakes for Japanese, 2010. Tokyo: Daiichi-shuppan; 2009.
Imai T, Nakamura M, Ando F, Shimokata H. Dietary supplement use by community-living population in Japan: data from the National Institute for Longevity Sciences Longitudinal Study of Aging (NILS-LSA). J Epidemiol. 2006;16:249–60.
Nanri A, Mizoue T, Noda M, et al. Magnesium intake and type II diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study. Eur J Clin Nutr. 2010;64:1244–7.
Tsugane S, Sobue T. Baseline survey of JPHC study–design and participation rate. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol. 2001;11:S24–9.
Sasaki S, Kobayashi M, Ishihara J, Tsugane S. Self-administered food frequency questionnaire used in the 5-year follow-up survey of the JPHC Study: questionnaire structure, computation algorithms, and area-based mean intake. J Epidemiol. 2003;13:S13–22.
Council for Science and Technology; Ministry of Education, Culture, Sports, Science and Technology, Japan. Standard tables of food composition in Japan. 5th revised and enlarged ed. Tokyo: National Printing Bureau; 2005.
Ishihara J, Inoue M, Kobayashi M, et al. Impact of the revision of a nutrient database on the validity of a self-administered food frequency questionnaire (FFQ). J Epidemiol. 2006;16:107–16.
Kato M, Noda M, Inoue M, Kadowaki T, Tsugane S. Psychological factors, coffee and risk of diabetes mellitus among middle-aged Japanese: a population-based prospective study in the JPHC study cohort. Endocr J. 2009;56:459–68.
Kosaka K. Diagnostic criteria for diabetes mellitus in Japan–from a report of the Japan Diabetes Society (JDS) Committee on the Diagnosis of Diabetes Mellitus, 1982. Diabetes Res Clin Pract. 1994;24(Suppl):S59–62.
Kirii K, Iso H, Date C, Fukui M, Tamakoshi A. Magnesium intake and risk of self-reported type 2 diabetes among Japanese. J Am Coll Nutr. 2010;29:99–106.
Villegas R, Gao YT, Dai Q, et al. Dietary calcium and magnesium intakes and the risk of type 2 diabetes: the Shanghai Women’s Health Study. Am J Clin Nutr. 2009;89:1059–67.
Hopping BN, Erber E, Grandinetti A, Verheus M, Kolonel LN, Maskarinec G. Dietary fiber, magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort in Hawaii. J Nutr. 2009;140:68–74.
Dong JY, Xun P, He K, Qin LQ. Magnesium intake and risk of type 2 diabetes: meta-analysis of prospective cohort studies. Diabetes Care. 2011;34:2116–22.
Guerrero-Romero F, Rascon-Pacheco RA, Rodriguez-Moran M, de la Pena JE, Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest. 2008;38:389–96.
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999;159:2151–9.
Guerrero-Romero F, Tamez-Perez HE, Gonzalez-Gonzalez G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004;30:253–8.
Hadjistavri LS, Sarafidis PA, Georgianos PI, et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit. 2010;16:CR307–12.
Lee S, Park HK, Son SP, Lee CW, Kim IJ, Kim HJ. Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults. Nutr Metab Cardiovasc Dis. 2009;19:781–8.
Mooren FC, Kruger K, Volker K, Golf SW, Wadepuhl M, Kraus A. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects – a double-blind, placebo-controlled, randomized trial. Diabetes Obes Metab. 2011;13:281–4.
Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006;23:1050–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nanri, A., Mizoue, T. (2013). Magnesium and Diabetes Prevention. In: Watson, R., Preedy, V., Zibadi, S. (eds) Magnesium in Human Health and Disease. Nutrition and Health. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-044-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-62703-044-1_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-043-4
Online ISBN: 978-1-62703-044-1
eBook Packages: MedicineMedicine (R0)